Depletion of excess liver copper ameliorates liver damage in a mouse model of chronic cholestatic liver disease

被引:0
|
作者
Koob, Dennis [1 ]
Nagel, Judith [2 ]
Li, Jingguo [1 ,3 ]
Zimny, Sebastian [1 ]
Wimmer, Ralf [1 ]
Denk, Gerald [1 ]
Roderfeld, Martin [4 ]
Roeb, Elke [4 ]
Lutsenko, Svetlana [5 ]
Zischka, Hans [2 ,6 ]
Hohenester, Simon [1 ]
机构
[1] Univ Hosp LMU, Dept Med 3, Munich, Germany
[2] Tech Univ Munich, Dept Toxicol & Environm Hyg, Munich, Germany
[3] Zunyi Med Univ, Dept Gastroenterol, Affiliated Hosp, Zunyi, Peoples R China
[4] Justus Liebig Univ, Gastroenterol Ctr Internal Med, Giessen, Germany
[5] Johns Hopkins Med Inst, Dept Physiol, Boston, MA USA
[6] Helmholtz Ctr Munich, Inst Mol Toxicol & Pharmacol, Munich, Germany
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-349
引用
收藏
页码:S417 / S417
页数:1
相关论文
共 50 条
  • [21] Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease
    Miyake, Teruki
    Yoshida, Sakiko
    Furukawa, Shinya
    Sakai, Takenori
    Tada, Fujimasa
    Senba, Hidenori
    Yamamoto, Shin
    Koizumi, Yohei
    Yoshida, Osamu
    Hirooka, Masashi
    Kumagi, Teru
    Niiya, Tetsuju
    Miyaoka, Hiroaki
    Masanori, Abe
    Matsuura, Bunzo
    Hiasa, Yoichi
    OPEN MEDICINE, 2018, 13 (01): : 402 - 409
  • [22] PROGNOSIS AND TREATMENT OF CHRONIC CHOLESTATIC LIVER-DISEASE
    TRIGER, DR
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1987, 50 (03): : 354 - 360
  • [23] Lidocaine for pruritus due to chronic cholestatic liver disease
    Tulsky, JA
    JOURNAL OF PALLIATIVE MEDICINE, 2006, 9 (03) : 818 - 819
  • [24] In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease
    Stevens, Kelly R.
    Scull, Margaret A.
    Ramanan, Vyas
    Fortin, Chelsea L.
    Chaturvedi, Ritika R.
    Knouse, Kristin A.
    Xiao, Jing W.
    Fung, Canny
    Mirabella, Teodelinda
    Chen, Amanda X.
    McCue, Margaret G.
    Yang, Michael T.
    Fleming, Heather E.
    Chung, Kwanghun
    de Jong, Ype P.
    Chen, Christopher S.
    Rice, Charles M.
    Bhatia, Sangeeta N.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (399)
  • [25] LACK OF OSTEOMALACIA IN CHRONIC CHOLESTATIC LIVER-DISEASE
    STELLON, AJ
    WEBB, A
    COMPSTON, J
    WILLIAMS, R
    BONE, 1986, 7 (03) : 181 - 185
  • [26] Epithelial to mesenchymal transition in chronic cholestatic liver disease
    Robertson, H
    Xu, X
    Burt, AD
    Kirby, JA
    JOURNAL OF PATHOLOGY, 2005, 207 : 30 - 30
  • [27] Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease.
    Hay, JE
    Guichelaar, MM
    Clarke, BL
    Malinchoc, M
    HEPATOLOGY, 2001, 34 (04) : 199A - 199A
  • [28] Gut microbiome in liver pathophysiology and cholestatic liver disease
    Yan, Shengmin
    Yin, Xiao-Ming
    LIVER RESEARCH, 2021, 5 (03) : 151 - 163
  • [29] Neutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease
    Yu, Muxin
    Li, Xiaowen
    Xu, Long
    Zheng, Chuwei
    Pan, Weiwei
    Chen, Hui
    Liu, Xiaoyu
    Zhang, Xianshan
    Zhang, Jinming
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (08)
  • [30] Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model
    Ceci, Ludovica
    Chen, Lixian
    Baiocchi, Leonardo
    Wu, Nan
    Kennedy, Lindsey
    Carpino, Guido
    Kyritsi, Konstantina
    Zhou, Tianhao
    Owen, Travis
    Kundu, Debjyoti
    Sybenga, Amelia
    Isidan, Abdulkadir
    Ekser, Burcin
    Franchitto, Antonio
    Onori, Paolo
    Gaudio, Eugenio
    Mancinelli, Romina
    Francis, Heather
    Alpini, Gianfranco
    Glaser, Shannon
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2022, 14 (04): : 877 - 904